Compensatory Arrangements of Certain Officers
On December 16, 2008, the Compensation Committee of the Board of Directors
of Geron Corporation (the "Company") approved (a) annual base salaries for 2009,
which are the same as the 2008 annual base salaries and (b) cash performance
bonuses for 2008 for the following principal executive officer, principal
financial officer and named executive officers of the Company:
--------------------------------------------------------------------------------------------------
2009
Salary 2009 2008
Name and Position Increase Base Salary Cash Bonus
--------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------
Thomas B. Okarma, Ph.D., M.D. $ -- $ 535,000 $ 280,900
President and CEO
--------------------------------------------------------------------------------------------------
David L. Greenwood $ -- $ 415,000 $ 163,400
Executive Vice President and CFO
--------------------------------------------------------------------------------------------------
Fabio M. Benedetti, M.D. $ -- $ 350,000 $ 102,300
Senior Vice President, Chief Medical
Officer, Oncology
--------------------------------------------------------------------------------------------------
David J. Earp, J.D., Ph.D. $ -- $ 325,000 $ 113,800
Senior Vice President, Bus. Dev. and
Chief Patent Counsel
--------------------------------------------------------------------------------------------------
Calvin B. Harley, Ph.D. $ -- $ 315,000 $ 96,500
Chief Scientific Officer
--------------------------------------------------------------------------------------------------
Melissa Kelly Behrs $ -- $ 320,000 $ 112,000
Senior Vice President, Therapeutic
Development, Oncology
--------------------------------------------------------------------------------------------------
Jane S. Lebkowski, Ph.D. $ -- $ 335,000 $ 117,300
Senior Vice President, Regenerative
Medicine
--------------------------------------------------------------------------------------------------
|